Colgate-Palmolive Company
CL
$91.75
$0.690.76%
Weiss Ratings | CL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Good | |||
Risk Index | Fair | |||
Risk Grade | C- | |||
Reward Grade | B | |||
Rating Factors | CL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Fair | |||
Growth Index | Good | |||
Efficiency Index | Excellent | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | CL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.15 | |||
Price History | CL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -0.59% | |||
30-Day Total Return | 4.80% | |||
60-Day Total Return | -2.98% | |||
90-Day Total Return | -6.78% | |||
Year to Date Total Return | 1.90% | |||
1-Year Total Return | 7.53% | |||
2-Year Total Return | 31.17% | |||
3-Year Total Return | 28.52% | |||
5-Year Total Return | 42.24% | |||
52-Week High % Change | -16.06% | |||
52-Week Low % Change | 7.54% | |||
Price | CL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $109.30 | |||
52-Week Low Price | $85.32 | |||
52-Week Low Price (Date) | Feb 18, 2025 | |||
52-Week High Price (Date) | Sep 05, 2024 | |||
Valuation | CL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 74.46B | |||
Enterprise Value | 82.05B | |||
Price/Earnings (TTM) | 26.06 | |||
Earnings Per Share (TTM) | 3.52 | |||
Earnings Per Share Growth | 26.81% | |||
Price/Earnings To Growth | 0.97 | |||
Price/Sales (TTM) | 3.74 | |||
Price/Book (Q) | 351.67 | |||
Enterprise Value/Revenue (TTM) | 4.08 | |||
Price | $91.75 | |||
Enterprise Value/EBITDA (TTM) | 16.93 | |||
Enterprise Value/EBIT | 19.35 | |||
Market Cap Category | Large Cap | |||
Dividends and Shares | CL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 819.70M | |||
Dividend Yield | 2.18% | |||
Div. Per Share (Most Recent) | $0.50 | |||
Dividend Per Share (TTM) | $2.00 | |||
Payout Ratio (TTM) | 61.90% | |||
Dividend Per Share (Most Recent) | $0.50 | |||
Company Info | CL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 212 310 2000 | |||
Address | 300 Park Avenue New York, NY 10022-7499 | |||
Website | www.colgatepalmolive.com | |||
Country | United States | |||
Year Founded | 1806 | |||
Profitability | CL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 21.09% | |||
Profit Margin | 14.37% | |||
Management Effectiveness | CL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 16.34% | |||
Return on Equity | 406.53% | |||
Income Statement | CL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 20.10B | |||
Total Revenue (TTM) | 20.10B | |||
Revenue Per Share | $24.52 | |||
Gross Profit (TTM) | 12.17B | |||
EBITDA (TTM) | 4.85B | |||
EBIT (TTM) | 4.24B | |||
Net Income (TTM) | 2.89B | |||
Net Income Avl. to Common (TTM) | 2.89B | |||
Total Revenue Growth (Q YOY) | -0.10% | |||
Earnings Growth (Q YOY) | 2.50% | |||
EPS Diluted (TTM) | 3.52 | |||
EPS Diluted Growth (Q YOY) | 3.37% | |||
Balance Sheet | CL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 1.26B | |||
Cash Per Share (Q) | $1.53 | |||
Total Current Assets (Q) | 5.32B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 544.00M | |||
Current Ratio (Q) | 0.923 | |||
Book Value Per Share (Q) | $0.26 | |||
Total Assets (Q) | 16.05B | |||
Total Current Liabilities (Q) | 5.76B | |||
Total Debt (Q) | 8.51B | |||
Total Liabilities (Q) | 15.50B | |||
Total Common Equity (Q) | 212.00M | |||
Cash Flow | CL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -534.00M | |||
Cash from Financing (TTM) | -3.39B | |||
Net Change in Cash (TTM) | 130.00M | |||
Levered Free Cash Flow (TTM) | 3.31B | |||
Cash from Operations (TTM) | 4.11B | |||